CYP2E1 and metabolic dysfunction-associated steatohepatitis: NASH has been correlated with direct lipid toxicity, impaired mitochondrial function, elevated cytochrome P450 activity (specifically CYP2E1 and CYP4A10/4A14), oxidative damage and increased inflammatory cytokines levels in the liver and periphery [9].